Employing UCN‐01 to activate FoxO3 in lung fibrosis, this agent was found to inhibit proliferation of IPF fibroblasts as well as donor fibroblasts that were stimulated by FCS, PDGF‐BB, or IGF‐1. This evidence concerns the gene FOXO3 and pulmonary fibrosis.